Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222377 · ClinicalTrials.gov registry record · NA
Endoscopic Breast Surgery in Treating Patients With Breast Cancer
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01222377: Clinical Trial NA study, sponsored by University of Southern California.
NCT01222377 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01222377, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE endoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-10 |
| Phase | NA |
Why NCT01222377 stopped before completion
NCT01222377 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT01222377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01222377 about?
NCT01222377 is a clinical study titled "Endoscopic Breast Surgery in Treating Patients With Breast Cancer". RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
What is the current status of trial NCT01222377?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01222377?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), endoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01222377?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01222377's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia